A novel use of recombinant factor VIIa in HELLP syndrome associated with spontaneous hepatic rupture and abdominal compartment syndrome.
Dart
Benjamin W
BW
Department of Surgery, Division of Surgical Critical Care, University of Tennessee College of Medicine, Chattanooga Unit, Chattanooga, Tennessee 37403, USA.
Cockerham
W Todd
WT
Torres
Carlos
C
Kipikasa
Joseph H
JH
Maxwell
Robert A
RA
D000328:Adult; D003161:Compartment Syndromes / Q000150:complications / Q000628:therapy*; D019299:Decompression, Surgical; D003937:Diagnosis, Differential; D005167:Factor VII / Q000627:therapeutic use*; D015942:Factor VIIa; D005260:Female; D017359:HELLP Syndrome / Q000150:complications / Q000628:therapy*; D006801:Humans; D008107:Liver Diseases / Q000150:complications / Q000628:therapy*; D017713:Platelet Transfusion; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011994:Recombinant Proteins / Q000627:therapeutic use*; D012422:Rupture, Spontaneous
D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa